Recent Advances and Challenges in the Treatment of Major Depressive Disorder

Recent Advances and Challenges in the Treatment of Major Depressive Disorder

Kim, Yong-Ku

Springer Verlag, Singapore

09/2024

426

Dura

9789819744015

15 a 20 dias

Descrição não disponível.
Part I. Molecular Biology-based Treatment for Depression.- Chapter 1. Neuroendocrinological Treatment Targets for Depressive Disorder.- Chapter 2. Psychophamacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorder.- Chapter 3. Efficacy, Safety and Tolerability of Psychedelics in Treatment Resistant Depression (TRD).- Chapter 4. Probiotics and Fecal Microbiota Transplantation in Major Depression: Doxa or Episteme?.- Chapter 5. Induced Pluripotent Stem Cells (iPSC) Technology for Major Depression.- Chapter 6. Combining Complementary and Alternative Medicine (CAM) with Conventional Treatments for Major Depressive Disorder.- Part II. Brain Network-based Treatments for Depression.- Chapter 7. Application of Transcranial Direct and Alternating Current Stimulation (tDCS & tACS) on Major Depressive Disorder.- Chapter 8. Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression.- Chapter 9. Deep Brain Stimulation (DBS) in Treatment-resistant Depression (TRD): Hope and Concern.- Chapter 10. Electroconvulsive Therapy (ECT) in Major Depression: Oldie but Goodie.- Part III. Psychological Intervention based Treatments for Depression.- Chapter 11. Cognitive Behavioral Therapy and Mindfulness-based Cognitive Therapy for Depressive Disorders: Enhancing Access and Tailoring Interventions in Diverse Settings.- Chapter 12. Acceptance and Commitment Therapy for Major Depressive Disorder: Navigating Depression Treatment in Traditional and Digital Settings with Insights from Current Research.- Chapter 13. The Importance of Psychotherapy for Treatment Resistant Depression.- Chapter 14. Personalized Well-Being Therapy (WBT) for Major Depression.- Part IV. Digital Psychiatry based Treatments for Depression.- Chapter 15. The Potential and Challenges of Virtual Reality as an Adjunctive Treatment of Depression Patients.- Chapter 16. The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics.- Chapter 17. Telepsychiatry in the Treatment of Major Depressive Disorders.- Part V. Personalized Precision Treatments for Depression.- Chapter 18. Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.- Chapter 19. Biomarker Guided Tailored Therapy in Major Depression.- Chapter 20. Navigating the Intersection of Technology and Depression Precision Medicine.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Antidepressant;Neuroinflammation;Pathophysiology;Depression;Ketamine